Press Releases

NovaBay® Pharmaceuticals, Inc. a company developing and commercializing high-quality eyecare, skincare and wound care products, announces that it will be sponsoring dry eye educational programs and offering special promotions on its Avenova®-branded eyecare products to customers and eyecare professionals throughout July in support of National Dry Eye Awareness Month. “Dry eye can be attributed to many factors such as exposure to air pollution and indoor heating and coo

A biotechnology company in China - Laekna, Inc today listed on the Main Board of The Stock Exchange of Hong Kong Limited. Laekna offered a total of 63,728,000 Shares in the global offering. The offer price was determined at HK$12.41 per offer share. The Company intends to use the net proceeds for the following purposes: (1) Use for rapidly advancing the clinical development and approval of one of the Company's Core Products, LAE001. (2) Use for advancing the clinical development

Meissa Vaccines  a clinical-stage biotechnology company developing vaccines to prevent viral respiratory infections, today announced it has entered into a manufacturing agreement with Exothera S.A. ("Exothera"), a Univercells company and full-service Contract Research Development and Manufacturing Organization (CRDMO) delivering customized process development and GMP manufacturing services for vaccines, viral vectors and nucleic acids. Under the agreement, Exothera will manufac

Mespack, a leading manufacturer of innovative and sustainable flexible packaging solutions, participated with great success in the last edition of Interpack 2023, one of the most significant fairs of the packaging industry, which took place in Düsseldorf (Germany). At this editon of the event, the company strengthened its role as a leading company of the flexible packaging industry, due to its commitment to develop sustainable and smart machines. In a presence of a large number

Oncodesign Services, a leading Contract Research Organization (CRO) specialized in drug discovery and preclinical services in oncology and immuno-inflammation, announces the execution of a Preclinical License and Supply Agreement with ImaginAb Inc. for the use of their investigational CD8 ImmunoPET™ (89Zr crefmirlimab berdoxam) technology. ImaginAb, a biotechnology company, developed CD8 ImmunoPET™, a 89Zr PET imaging agent to enable the whole body visualization of the immune syst

From 1 July 2023, Professor Josef Penninger takes over the Scientific Management of the Helmholtz Centre for Infection Research (HZI). Penninger is internationally renowned for his outstanding contributions to genetic and molecular biology. Joining HZI from the University of British Columbia (Canada), where he had led the Life Sciences Institute, he starts his position as head of the interdisciplinary infection research center in Braunschweig. Penninger is taking over the role of Professor Di

Every year the European Association of the Self-Adhesive Label Industry (FINAT) recognizes the industry’s best products. This year the Smart Blister Card from Schreiner MediPharm was the winner in the prestigious “Innovation & Electronic Printing – Electronic Devices” category. It extends standard multi-dose blister packs by a digital adherence monitoring tool enabling tracking of medication intake in real time. Polypharmacy describes permanent therapies

Biotium, a leading provider of innovative life science solutions, is thrilled to announce the release of its latest product, Mix-n-Stain™ CF® Dye IgM Antibody Labeling Kits. These groundbreaking kits revolutionize the labeling process for IgM antibodies, enabling researchers to easily obtain high-performance fluorescent IgM conjugates with minimal hands-on time with no purification after labeling. IgM antibodies offer advantages over IgG antibodies due to their increased a

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, today announced U.S. Food and Drug Administration (FDA) accelerated approval of ELEVIDYS (delandistrogene moxeparvovec-rokl), an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene. This indication is approved under accelerated approval based on expression of ELEV

Genomic Vision, a Euronext-listed biotechnology company that develops products and services for the highly accurate characterization of DNA sequences, is pleased to announce an exclusive European distribution agreement with CliniSciences. CliniSciences is a major European distributor of innovative products and services in Life Science Research with a particular focus on oncology. CliniSciences and Genomic Vision will work closely together to leverage their respective resources, indu